Insiders / Skvarka Jan
Skvarka Jan
CIK 1838042personinsider
Companies
3
First seen
Jan 4, 2021
Last activity
Jun 18, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Zentalis Pharmaceuticals, Inc. · ZNTL | 264,254 | — |
| Trillium Therapeutics Inc. · TRIL | 0 | — |
| Monte Rosa Therapeutics, Inc. · GLUE | — | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Zentalis Pharmaceuticals, Inc. | Common stock | 264,254 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Monte Rosa Therapeutics, Inc. | Options | 25,800 |
| Trillium Therapeutics Inc. | Options | 1,250,000 |
Other
| Company | Security | Shares |
|---|---|---|
| Zentalis Pharmaceuticals, Inc. | Unclassified | 149,551 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 11, 2021 | Sell Open-market sale | TRIL Trillium Therapeutics Inc. Common Shares | $981.8K | -107K -100.00% | 0 | medium |
| Jan 14, 2021 | Sell Open-market sale | TRIL Trillium Therapeutics Inc. Common Shares | $294.3K | -20K -100.00% | 0 | medium |
| May 12, 2021 | Sell Open-market sale | TRIL Trillium Therapeutics Inc. Common Shares | $219.9K |